AHA 2026: A simpler pill regimen, better blood pressure control

Clinical takeaway: For patients with uncontrolled hypertension, consider single-pill combinations alongside structured follow-up, home monitoring, and adherence support. These findings support pairing simpler prescribing with coordinated care.

Treatment burden and delays in intensifying therapy can leave hypertension uncontrolled despite available medications. Single-pill combinations simplify regimens, but evidence on implementing them in routine practice over the long term has been limited.

In the CATCH trial, 69.5% of patients receiving single-pill combinations through team-based care achieved blood pressure below 130/80 mm Hg at 18 months, compared with 29.2% receiving standard care—a 40-percentage-point difference. Systolic pressure fell by 19.1 versus 9.0 mm Hg, an additional reduction of approximately 10 mm Hg.

Benefits persisted but narrowed six months after the intervention ended: 55.8% versus 34.2% had controlled blood pressure. Serious adverse events occurred at similar frequencies in the two groups.

Researchers randomized 40 primary care clinics in Colombia and Jamaica, enrolling 1,706 adults with uncontrolled hypertension, to the combined strategy or standard care. The intervention included study-funded combination pills, clinician training, health coaching, and home monitoring. The primary outcome was the between-group difference in systolic pressure change at 18 months.

Wider adoption will require reliable access to affordable combination pills and integration into routine care. The authors also called for trials comparing cardiovascular outcomes with single-pill combinations versus stepped-care usual care.

“From clinical and public health perspectives, adoption of the combined strategy is more relevant than adoption of any individual component,” the authors wrote.

Source: Lopez-Lopez JP, et al. (2026 Nov 8) JAMA. Implementation of Single-Pill Combination Therapy Through Team-Based Care for Hypertension Control in Resource-Constrained Settings: A Cluster Randomized Clinical Trial